Acutus Medical saw the highest growth of 2.99% in patent filings in June and 0.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.49% and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Acutus Medical’s patent filings and grants. Buy the databook here.
Acutus Medical has been focused on protecting inventions in European Patent Office(EPO) with three publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 29% filings and 50% grants. The United States(US), European Patent Office(EPO), Australia(AU), and Japan(JP) patent Office are among the top ten patent offices where Acutus Medical is filings its patents. Among the top granted patent authorities, Acutus Medical has 50% of its grants in European Patent Office(EPO) and 50% in Israel(IL).
Boston Scientific and Johnson & Johnson could be the strongest competitors for Acutus Medical
In terms of grant share, Acutus Medical stands in fourth position among its competitors. Boston Scientific and Johnson & Johnson secured the top positions according to recent patent publication data.
Patents related to healthtech and directed energy weapons lead Acutus Medical's portfolio
Acutus Medical has the highest number of patents in healthtech followed by, directed energy weapons. For healthtech, nearly 83% of patents were filed and 100% of patents were granted in Q2 2024.
General surgery devices related patents lead Acutus Medical portfolio followed by diagnostic imaging, and cardiovascular devices
Acutus Medical has highest number of patents in general surgery devices followed by diagnostic imaging, cardiovascular devices, healthcare it. For general surgery devices, nearly 67% of patents were filed and 40% of patents were granted in Q2 2024.
For comprehensive analysis of Acutus Medical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.